EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-23,965
-30,577
-8,732
-2,941
-3,497
Depreciation & amortization
4,757
3,447
282
116
46
Deferred income taxes
294
-24
-
-
-
Stock based compensation
11,906
7,498
2,822
681
1,176
Change in working capital
-4,084
-1,065
-1,822
116
-23
Accounts receivable
-4,302
-3,196
-224
13
0
Inventory
-14,084
-2,921
-333
-129
-164
Accounts Payable
5,187
6,222
-879
-
-
Other working capital
-62,191
-47,772
-10,073
-2,293
-2,548
Other non-cash items
-
225
-
0
1,176
Net cash provided by operating activites
-37,998
-29,089
-7,816
-2,048
-2,278
Cash flows from investing activities
Investments in property, plant and equipment
-24,193
-18,682
-2,257
-245
-270
Acquisitions, net
-24,368
-41,797
-16,230
-
-
Purchases of investments
-
0
-250
-
-
Sales/Maturities of investments
-
-
-
-
-
Other investing activites
-
-2,000
-196
0
-42
Net cash used for investing activites
-50,561
-62,479
-18,933
-244
-312
Cash flows from financing activities
Debt repayment
-2,736
-92
-
-
-
Common stock issued
25,550
60,600
40,941
-
-
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-5,976
-473
-3,151
5,154
953
Net cash used privided by (used for) financing activities
18,498
83,087
68,055
5,427
953
Net change in cash
-70,061
-8,481
41,306
3,135
-1,637
Cash at beginning of period
72,676
44,523
3,217
82
1,719
Cash at end of period
2,615
36,042
44,523
3,217
82
Free Cash Flow
Operating Cash Flow
-37,998
-29,089
-7,816
-2,048
-2,278
Capital Expenditure
-24,193
-18,682
-2,257
-245
-270
Free Cash Flow
-62,191
-47,772
-10,073
-2,293
-2,548